Alcon Inc., CH0432492467

Alcon schedules November 10 results as Alcon stock costs EUR 57.28

Published on 10/13/2026 at 13:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Consensus calls for USD 0.89 earnings per share for September 2026. Alcon stock costs EUR 57.28 on October 13, 2026 at 1:37 p.m. CEST.

  • Alcon's next earnings release is scheduled for November 10, 2026, with consensus earnings per share of USD 0.89 for September 2026.
  • Alcon stock was at EUR 57.28 at Lang & Schwarz on October 13, 2026 at 1:37 p.m. CEST.
  • The stock's price-to-earnings ratio was 49.50 and its market capitalization was USD 31.4 billion.
  • Alcon trades on SIX under ticker ALC, while The Cooper Companies had a 18.96 price-to-earnings ratio and USD 10.8 billion market capitalization.
Flat lay product photography on white marble. Contact lens case, lens solution bottle, soaking dish, and optometry trial lens kit arranged neatly with soft studio overhead lighting, clinical cleanliness, no text on items
Alcon CH0432492467: Flatlay mit Kontaktlinsenbehälter, Pflegelösung und Probierlinsen Set auf weißem Marmor, Illustration mit AI erstellt.

Alcon stock was at EUR 57.28 at Lang & Schwarz on October 13, 2026 at 1:37 p.m. CEST. The next earnings release is scheduled for November 10, 2026, and consensus calls for USD 0.89 earnings per share for the quarter ending September 2026, according to Zacks.

November 10 report date

The November release gives the market a defined checkpoint after Alcon reported USD 0.84 earnings per share for its latest reported quarter, compared with a USD 0.77 consensus estimate, according to Zacks. The same source lists the September 2026 consensus at USD 0.89 earnings per share, giving investors a concrete benchmark for the next report.

Alcon's investor-relations page describes a portfolio spanning Surgical and Vision Care products, serving people in more than 140 countries and supported by more than 25,000 associates, according to Alcon. That mix leaves the November release relevant for both procedure-related demand and consumer eye-care products.

Price and valuation

The finance snapshot for Alcon's NYSE listing showed a price-to-earnings ratio of 49.50 and a market capitalization of USD 31.4 billion on October 12, 2026. The same listing carried a 52-week range of USD 61.84 to USD 87.64, with the USD 64.35 price near the lower end of that interval.

Alcon's Swiss listing was identified as ALC on SIX under ISIN CH0432492467 by Global Banking and Finance Review. The page records a CHF 53.14 close on October 9, 2026, while the euro quote provides the current German-market reference for this report.

Comparison with peers

Alcon: P/E 49.50, market capitalization USD 31.4 billion

The Cooper Companies (NYSE, USD): P/E 18.96, market capitalization USD 10.8 billion

EssilorLuxottica (NYSE, USD): P/E 27.36, market capitalization USD 75.4 billion

The current euro quote

Alcon stock was trading at EUR 57.28 at Lang & Schwarz on October 13, 2026 at 1:37 p.m. CEST. The bid was EUR 57.26 and the ask was EUR 57.30, putting the spread at EUR 0.04.

The further course of trading is shown by the continuously updated real-time quote of Alcon stock.

Alcon stock at a glance

  • Company: Alcon Inc.
  • ISIN: CH0432492467
  • Ticker: ALC
  • Primary exchange: SIX
  • Price Lang & Schwarz as of October 13, 2026, 1:37 p.m. CEST: EUR 57.28
  • Market capitalization: USD 31.4 billion as of October 12, 2026
  • Sector / Industry: Health Care / Medical Instruments

Market context: Market report SMI.

More news and analyses on Alcon stock

Disclaimer...

en | CH0432492467 | ALCON INC. | boerse | 70314138 | bgmi